Showing results (131-140 of 165) with videos related to
Sort By:
Pageof 17
Journal of the American Dental Association (1939)|September 1, 1986
Intraoral effects of a fluoride-releasing device on acid-softened enamelR E Corpron, J W Clark, A Tsai, et al.The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1996
1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cellsM L Siu-Caldera, J W Clark, A Santos-Moore, et al.The New England Journal of Medicine|June 2, 1988
Resistance to recombinant interferon alfa-2a in hairy-cell leukemia associated with neutralizing anti-interferon antibodiesR G Steis, J W Smith, W J Urba, et al.AJNR. American Journal of Neuroradiology|January 1, 1987
Chemonucleation and changes observed on lumbar MR scan: preliminary reportM S Huckman, J W Clark, T W McNeill, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|February 1, 1995
Changes in tyrosine-phosphorylated p190 and its association with p120 type I and p100 type II rasGAPs during myelomonocytic differentiation of human leukemic cellsJ C Cheng, A R Frackelton, E L Bearer, et al.Princess Takamatsu Symposia|January 1, 1984
HTLV: epidemiology and relationship to diseaseW A Blattner, J W Clark, W N Gibbs, et al.Cancer|April 1, 1988
Molecular epidemiology of HTLV-I-associated non-Hodgkin's lymphomas in JamaicaJ W Clark, C Gurgo, G Franchini, et al.Blood|January 1, 1989
Deoxycoformycin-induced immunosuppression in patients with hairy cell leukemiaW J Urba, M W Baseler, W C Kopp, et al.American Journal of Clinical Oncology|October 1, 1990
A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinomaM Posner, C A Slapak, M J Browne, et al.Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|October 1, 1991
Phase I evaluation of recombinant tumor necrosis factor given in combination with recombinant interferon-gammaJ W Smith, W J Urba, J W Clark, et al.Pageof 17